TY  - GEN
AU  - Chlebowski,R T
AU  - Anderson,G L
AU  - Sarto,G E
AU  - Haque,R
AU  - Runowicz,C D
AU  - Aragaki,A K
AU  - Thomson,C A
AU  - Howard,B V
AU  - Wactawski-Wende,J
AU  - Chen,C
AU  - Rohan,T E
AU  - Simon,M S
AU  - Reed,S D
AU  - Manson,J E
TI  - Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial
SN  - 1460-2105
PY  - 2016///0219
KW  - Aged
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Endometrial Neoplasms
KW  - chemically induced
KW  - Estrogen Replacement Therapy
KW  - adverse effects
KW  - Estrogens, Conjugated (USP)
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Hysterectomy
KW  - Incidence
KW  - Kaplan-Meier Estimate
KW  - Medroxyprogesterone Acetate
KW  - Middle Aged
KW  - Odds Ratio
KW  - Postmenopause
KW  - United States
KW  - epidemiology
KW  - Women's Health
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1093/jnci/djv350
ER  -